Dr. Joshua Lo, DO – San Jose, CA
Dylan Hughes
Published Mar 25, 2026
KRAS mutation as predictor for cause-specific survival in early- versus late-onset colorectal cancer: A United States population-based study.
Lin, A.Y., Khal, A.R., Pan, J.Y., Lo, J., Tung, W., Fisher, G.A., Chariton, M.E., Journal of Clinical Oncology, 2019
